Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma

Small-molecule inhibitor of apoptosis (IAP) antagonists, called Smac mimetic compounds (SMCs), sensitize tumours to TNF-α-induced killing while simultaneously blocking TNF-α growth-promoting activities. SMCs also regulate several immunomodulatory properties within immune cells. We report that SMCs s...

Descripción completa

Detalles Bibliográficos
Autores principales: Beug, Shawn T., Beauregard, Caroline E., Healy, Cristin, Sanda, Tarun, St-Jean, Martine, Chabot, Janelle, Walker, Danielle E., Mohan, Aditya, Earl, Nathalie, Lun, Xueqing, Senger, Donna L., Robbins, Stephen M., Staeheli, Peter, Forsyth, Peter A., Alain, Tommy, LaCasse, Eric C., Korneluk, Robert G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330852/
https://www.ncbi.nlm.nih.gov/pubmed/28198370
http://dx.doi.org/10.1038/ncomms14278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330852/
https://www.ncbi.nlm.nih.gov/pubmed/28198370
http://dx.doi.org/10.1038/ncomms14278

Ejemplares similares